Gastroenterology encompasses a vast area of indications covering Inflammatory Bowel Disease, Crohns and Ulcerative Colitis to Irritable bowel syndrome and chronic constipation.
Historically treatment goals for chronic diseases revolved around avoiding surgery; which has become a realistic outcome with the introduction and usage of biologics. Growing license extensions has led to increased availability to patients, with the introduction of biosimilars bringing more players into the market.
Support programmes focus around patients getting more from their treatment, with a growing influx of offerings and ways in which companies can differentiate themselves.
Experienced Consultants in Gastroenterology
Our Therapy Area Team will work closely with you to help identify the most suitable approach, challenge when necessary and provide actionable insights to help navigate your marketing challenges. We have dedicated Senior Consultants and Therapy Area Teams that keep abreast of the full market landscape.
Adelphi MarketMapsTM have been developed to summarise and visualise the full market landscape including the key challengers, market trends and the likely impact of pipeline treatments.
The Types of Challenges we Help to Solve
- Assessing patient support programs and tools
- Understanding the patient journey and experiences
- Campaign development and testing, ensuring campaigns reflect reality
- Assessing the impact of biosimilars on the market landscape
- Market tracking research